Jammu & Kashmir Bank to Sell 0.5% PNB Metlife Stake for ₹120 Crore

BANKINGFINANCE
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
Jammu & Kashmir Bank to Sell 0.5% PNB Metlife Stake for ₹120 Crore

Jammu & Kashmir Bank has formalized an escrow agreement to complete its divestment of a 0.5% stake in PNB Metlife India Insurance. The deal, valued at ₹120.10 crore, follows a prior share purchase agreement and utilizes Barclays as an escrow agent to facilitate the transaction process.

Jammu & Kashmir Bank Finalizes Escrow for PNB Metlife Stake Sale

Transaction Value: ₹120.10 crore.
Stake Sold: 0.5% in PNB Metlife India Insurance.

Reader Takeaway: This divestment unlocks capital for J&K Bank while following through on previously announced strategic plans.

What just happened

Jammu & Kashmir Bank has entered into an Escrow Agreement to facilitate the sale of its 0.5% equity stake in PNB Metlife India Insurance Company. The transaction involves a total consideration of ₹120.10 crore at a price of ₹117.20 per share. This agreement follows an initial Share Purchase Agreement signed on July 17, 2026, with MetLife International Holdings, LLC.

Why this matters

The execution of this agreement acts as a procedural milestone for the bank’s divestment strategy. By appointing Barclays Wealth Trustees (India) Private Limited and Barclays Bank PLC as independent escrow agents, the bank ensures a secure and transparent transfer of shares and cash. This marks a definitive step toward closing the divestment process initiated earlier this year.

Governance and Terms

The bank confirmed that the transaction is conducted at arm’s length. There are no related-party interests involved in this deal. Furthermore, no special rights, such as board representation or subscription privileges, were granted to the escrow agents. The bank maintains no shareholding connection with the appointed agents, ensuring the transaction remains straightforward and independent.

What to track next

Investors should watch for the official completion notice and the subsequent impact on the bank's non-core asset portfolio. This sale represents a strategic move to monetize minority investments, potentially aiding the bank’s capital adequacy position.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.